MustGrow Biologics Corp. (TSXV:MGRO)

Canada flag Canada · Delayed Price · Currency is CAD
0.8800
+0.0200 (2.33%)
Jul 15, 2025, 2:46 PM EDT
18.92%
Market Cap 46.10M
Revenue (ttm) 4.18M
Net Income (ttm) -5.49M
Shares Out 52.39M
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,000
Average Volume 9,946
Open 0.8500
Previous Close 0.8600
Day's Range 0.7800 - 0.8800
52-Week Range 0.5100 - 2.5300
Beta 2.26
RSI 52.80
Earnings Date Aug 26, 2025

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage... [Read more]

Sector Materials
Founded 2014
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol MGRO
Full Company Profile

Financial Performance

In 2024, MustGrow Biologics's revenue was 398,018, a decrease of -91.55% compared to the previous year's 4.71 million. Losses were -4.89 million, 622.2% more than in 2023.

Financial Statements

News

MustGrow Biologics GAAP EPS of -C$0.03

7 weeks ago - Seeking Alpha

MustGrow Biologics accelerates regenerative agriculture with NexusBioAg acquisition

MustGrow Biologics is focused on driving the future of agriculture — through science-based innovation and a deep commitment to biological and regenerative solutions.

2 months ago - BNN Bloomberg